ISRG vs MBOT
ISRG: Intuitive is the global leader in robotic-assisted surgical technology, providing systems and digital tools that enable clinicians to perform complex procedures with greater precision and minimally invasive access. MBOT: Microbot Medical develops compact, disposable, and remotely operated robotic systems designed to modernize minimally invasive endovascular surgery.
Side-by-side fundamentals
| Metric | ISRG | MBOT | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $438.00 | $0.9475 | |
| Market cap | $154.7B | $64M | |
| P/E as of 2026-10-20 | 50.23 | n/a | |
| PEG as of 2026-10-20, 3-year EPS CAGR to FY2025 | 1.72 | n/a | |
| Net margin FY2025, SEC XBRL | +28.4% | n/a | |
| Gross margin FY2025, SEC XBRL | +66.0% | n/a | |
| Operating margin FY2025, SEC XBRL | +29.3% | n/a | |
| ROE FY2025, SEC XBRL | +16.0% | -16.9% | ISRG higher |
| ROA FY2025, SEC XBRL | +14.0% | -16.1% | ISRG higher |
| Revenue growth (YoY) FY2025, SEC XBRL | +20.5% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +17.4% | -56.0% | ISRG higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-02 | 1.14 | 1.52 | |
| 1-year return as of 2026-10-20 close | -4.5% | -66.2% | ISRG higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.